Pure progressive amnesia and the APPV717G mutation

Alzheimer Disease and Associated Disorders

Volumn 23, Issue 4, 2009, Pages 410-414

  Knight, William D ^a   Ahsan, R Laila ^a   Jackson, Jessica ^b   Cipolotti, Lisa ^b   Warrington, Elizabeth K ^a   Fox, Nick C ^a   Rossor, Martin N ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Alzheimer disease; Amyloid precursor protein gene; Dementia; Familial Alzheimer disease; Pure progressive amnesia

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ADULT; ALZHEIMER DISEASE; AMNESIA; AMYGDALOID NUCLEUS; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRAIN ATROPHY; BRAIN SIZE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DISEASE COURSE; EPISODIC MEMORY; GENE MUTATION; GENOTYPE; HIPPOCAMPUS; HUMAN; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIGREE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; AGING; ALZHEIMER DISEASE; AMNESIA; AMYLOID BETA-PROTEIN PRECURSOR; ATROPHY; DISEASE PROGRESSION; FEMALE; GLYCINE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PHENOTYPE; VALINE;

EID: 75949120365     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31819cb7f3     Document Type: Article

References (32)

1. Lowenberg K, Waggoner R. Familial organic psychosis (Alzheimer's type). Arch Neurol Psychiatr. 1934;31:737-754.
2. Goate A, Chartierharlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimers-disease. Nature. 1991;349:704-706.
3. Horaitis O, Talbot CC Jr, Phommarinh M, et al. A database of locus-specific databases. Nat Genet. 2007;39:425.
4. Rovelet-Lecruz A, Hannequin D, Raux G, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. NatGenet. 2006;38: 24-26.
5. Gankam Kengne F, Vokaer M, Massat I, et al. Pure progressive amnesia as a variant of genetically proven Alzheimer's disease. Neurodegenerative Dis. 2007;4(suppl 1): 44-45.
6. Wechsler D. The Psychometric Tradition-developing the wechsler adult intelligence scale. Contemp Educ Psychol. 1981; 6:82-85.
7. Warrington EK. Manual for the Recognition Memory Test for WORDS and Faces. Windsor, UK: NFER-Nelson; 1984.
8. Warrington EK. The Camden Memory Tests. UK: Psychology Press; 1996.
9. Freeborough PA, Fox NC, Kitney RI. Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput Methods Programs Biomed. 1997;53:15-25.
10. Scahill RI, Schott JM, Stevens JM, et al. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA. 2002;99:4703-4707.
11. Kwok JB, Taddei K, Hallupp M, et al. Two novel (M233 T and R278 T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. Neuroreport. 1997;8:1537-1542.
12. Crook R, Verkkoniemi A, Perez-Tur J, et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med. 1998;4:452-455.
13. Houlden H, Baker M, McGowan E, et al. Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Ann Neurol. 2000;48:806-808.
14. Smith MJ, Kwok JB, McLean CA, et al. Variable phenotype of Alzheimer's disease with spastic paraparesis. Ann Neurol. 2001;49:125-129.
15. Brooks WS, Kwok JBJ, Kril JJ, et al. Alzheimer's disease with spastic paraparesis and "cotton wool" plaques: two pedigrees with PS-1 exon 9 deletions. Brain. 2003;126:783-791.
16. Styczynska M, Zekanowski C, Peplonska B, et al. Early onset Alzheimer's disease associated with a novel P117R presenilin 1 mutation and initial features of frontotemporal dementia. Eur J Neurol. 2004;11(suppl 2):p190 (abstract P2023).
17. Duarte N, Lozano J, Pena M, et al. Fronto-temporal dementia syndrome with parkinsonism in a Colombian family with E280A presenilin-1 mutation. Movement Disorders. 2004;19: S361.
18. Levy E, Carman MD, Fernandezmadrid IJ, et al. Mutation of the Alzheimers-disease amyloid gene in hereditary cerebralhemorrhage, dutch type. Science. 1990;248:1124-1126.
19. Hendriks L, Vanduijn CM, Cras P, et al. Presenile-dementia and cerebral-hemorrhage linked to a mutation at codon-692 of the Beta-amyloid precursor protein gene. Nat Genet. 1992;1: 218-221.
20. Barbeau EJ, Didic M, Felician O, et al. Pure progressive amnesia: an atypical amnestic syndrome? Cognit Neuropsychol. 2006;23:1230-1247.
21. Butters MA, Lopez OL, Becker JT. Focal temporal lobe dysfunction in probable Alzheimer's disease predicts a slow rate of cognitive decline. Neurology. 1996;46:687-692.
22. Stokholm J, Jakobsen O, Czarna JM, et al. Years of severe and isolated amnesia can precede the development of dementia in early-onset Alzheimer's disease. Neurocase. 2005;11:48-55.
23. Caselli RJ, Couce ME, Osborne D, et al. From slowly progressive amnesic syndrome to rapidly progressive Alzheimer disease. Alzheimer Dis Assoc Disorders. 1998;12:251-253.
24. Fossard M, Rigalleau F, Puel M, et al. Working memory and semantic involvement in sentence processing: a case of pure progressive amnesia. Neuropsychologia. 2006;44:335-338.
25. Jacobs D, Sano M, Marder K, et al. Age at onset of Alzheimers-disease- relation to pattern of cognitive dysfunction and rate of decline. Neurology. 1994;44:1215-1220.
26. Rogaeva E. The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease. Neuromolecular Med. 2002;2:1-10.
27. Sorbi S, Nacmias B, Forleo P, et al. Epistatic effect of App717 mutation and apolipoprotein-e genotype in familial Alzheimersdisease. Ann Neurol. 1995;38:124-127.
28. Stgeorgehyslop P, Mclachlan DC, Tuda T, et al. Alzheimersdisease and possible gene interaction. Science. 1994;263:537.
29. Frisoni GB, Pievani M, Testa C, et al. The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain. 2007;130:720-730.
30. Du AT, Schuff N, Kramer JH, et al. Higher atrophy rate of entorhinal cortex than hippocampus in AD, 62 ed.
31. Fox NC, Cousens S, Scahill R, et al. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease-Power calculations and estimates of sample size to detect treatment effects. Arch Neurol. 2000;57: 339-344.
32. Hashimoto M, Kazui H, Matsumoto K, et al. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? Am J Psychiatry. 2005;162: 676-682.